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The respiratory system, which includes the trachea, airways, and distal alveoli, is a complex multi-cellular or-
gan that intimately links with the cardiovascular system to accomplish gas exchange. In this review and as
members of the NIH/NHLBI-supported Progenitor Cell Translational Consortium, we discuss key aspects
of lung repair and regeneration. We focus on the cellular compositions within functional niches, cell-cell
signaling in homeostatic health, the responses to injury, and new methods to study lung repair and regener-
ation. We also provide future directions for an improved understanding of the cell biology of the respiratory
system, as well as new therapeutic avenues.Introduction
The respiratory system is organized into multiple integrated
compartments comprising multiple tissues that perform gas ex-
change between the blood and the external environment. The
various anatomical regions of the respiratory tract are populated
by numerous types of unique epithelial, vascular, mesenchymal,
and immune cells critical for the functioning of each particular
compartment.
Historically, the development of the respiratory system has
been thought to involve several discrete morphogenetic steps
including lineage specification, branchingmorphogenesis, saccu-
lation, and alveologenesis (Morrisey and Hogan, 2010). While
these steps were previously conceived of in terms of distinct tem-
poral stages of development, more recent evidence has sug-
gested that there is overlap between these stages and particular
events such as cell specification and commitment, which are
now thought to occur very early and coincident with the basic
patterning of the respiratory airway tree (Frank et al., 2019).
The branched network of airways and gas exchange surfaces
co-develops with the cardiovascular system to bring both organ
systems into intimate proximity for full functionality. More details
on these important developmental events can be found in
several recent reviews (Herriges and Morrisey, 2014; Hines and
Sun, 2014; Morrisey and Hogan, 2010; Nikolic et al., 2018; Whit-
sett et al., 2019; Zepp and Morrisey, 2019). The culmination of
these events is the generation of an extensive surface area for
efficient gas exchange that in the human lung comprises approx-
imately 70 m2.482 Cell Stem Cell 26, April 2, 2020 ª 2020 Published by Elsevier IncThis review will focus on how the mature respiratory system
maintains its normal homeostatic structure and function and
how it responds to injury and regenerates itself. We will explore
the cellular constituents of the two major compartments in the
lungs—the gas exchange alveoli and the conducting airways
including the trachea—and describe established and emerging
techniques to explore human lung regeneration.
Compartment-Specific Regeneration in the Respiratory
System
Alveolar Regeneration
The lung alveolus is composed of multiple epithelial, endothelial,
and mesenchymal cell types (Figure 1). In addition to these resi-
dent cell types, the alveolus also is inhabited by several immune
cell lineages, including alveolar macrophages, interstitial macro-
phages, and dendritic cells and several recent datasets have
shown this diversity of cells at single-cell resolution in both ani-
mals and humans (Guo et al., 2019; Travaglini et al., 2019; Vieira
Braga et al., 2019). Emerging data suggest there is some degree
of inter-cellular communication between the lineages in this niche,
but our understanding of the crosstalk among alveolar cell line-
ages during homeostasis or regeneration remains poor. The alve-
olar compartment remains largely quiescent in the uninjured lung,
and most cells within this niche exhibit a relatively slow turnover.
After lung injury, multiple alveolar cell types are able to proliferate,
and when repair is effective both alveolar structure and function
are restored. This ability to react to injury involves both activation
of self-renewal as well as differentiation into more mature cell.
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Figure 1. Alveolar Cell Lineages Involved in Lung Repair and Regeneration
(A) The human distal airways connect with the alveolar niche through a transitional respiratory airway (also called the respiratory bronchiole or RB) region. The RB
is lined with a simple but poorly characterized cuboidal epitheliumwhile themore intermediate airways exhibit a pseudostratified epithelium containing secretory,
goblet, and ciliated cells that may exhibit as yet distinct heterogeneity. Of note, basal cells are found in human intermediate and respiratory airways.
(B) Mice do not have respiratory bronchioles and transition from the intermediate airways, which exhibit a pseudostratified nature but lack basal cells, into the
alveolar region. The distal BADJ region in the mouse lung, which is not found in the human lung, contains the BASC population. The architecture and cell lineages
found in both themouse and human lungs are very similar and contain both AT1 and AT2 epithelial lineages aswell as variousmesenchymal lineages and vascular
endothelial cells.
(C) The various cell types found in the distal airways and alveolus of the human and mouse lung.
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Reviewlineages. The self-renewal and differentiation of various lung
epithelial cells are modulated by a growing list of cell types that
includes neighboring epithelial cells, mesenchymal cells, airway
smooth muscle, neurons and neuroendocrine cells, endothelium,
and various leukocyte populations (Barkauskas et al., 2013; Cao
et al., 2017; Lechner et al., 2017; Lee et al., 2017; Rafii et al., 2015;
Zepp et al., 2017). These studies have highlighted recurrent
themes regarding the signals that can drive alveolar epithelial
regeneration, including Wnt signaling.Alveolar Epithelial Response to Injury. There are two primary
lineages in the alveolar epithelium: the alveolar epithelial type 1
(AT1) and type 2 (AT2) cells (Figure 1). AT1 cells cover 95% of
the alveolar surface area and are closely juxtaposed with the
capillary plexus. AT2s are responsible for generating pulmonary
surfactant, which is essential for reducing the surface tension of
the alveolar surface area to prevent the lungs from collapsing
upon every breath. AT1 and AT2 cells are specified very early
in lung development and AT2 cells do not appreciably generateCell Stem Cell 26, April 2, 2020 483
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ReviewAT1 cells during early postnatal lung growth (Frank et al., 2016,
2019). However, in adult mice, AT2 cells can act as both a self-
renewing stem cell like population and regenerating AT1 cells af-
ter injury (Barkauskas et al., 2013). A sublineage within the AT2
cell population that expresses the transcriptional target of Wnt
signaling, Axin2, has been shown to play a dominant role in re-
pairing the lung alveolus after acute injury (Nabhan et al., 2018;
Zacharias et al., 2018). These cells, which have been called alve-
olar epithelial progenitors or AEPs, preferentially re-enter the cell
cycle after injury, self-renew, and regenerate mature AT1 and
AT2 cells. AEPs appear primed to enter the cell cycle and they
respond robustly to Wnt and Fgf7 signaling (Zacharias et al.,
2018). In alveolar development, Wnt-responsive AT2 cells self-
renew in the presence of Wnt signaling and differentiate in its
absence (Frank et al., 2016), but it is not yet knownwhether these
same signals drive renewal versus differentiation during regener-
ation. A recent report also shows that AEPs promote metastasis
inmodels of lung cancer (Laughney et al., 2020). AEPs have been
identified in the human lung and are responsible for generating
the majority of AT2 cell growth in human alveolar organoids
(Zacharias et al., 2018). In contrast to AT2s and AEPs, the AT1
cell contribution to alveolar epithelial regeneration is thought to
be very limited (Jain et al., 2015). Following the surgical removal
of lung tissue in adult mice and other model organisms, new al-
veoli are formed to compensate for lost alveolar surface area
(Buhain and Brody, 1973). This compensatory lung growth after
partial pneumonectomy is commonly used as a ‘‘sterile’’ model
of lung regeneration. Not surprisingly, this regenerative response
involves the coordinated actions of nearly every cell type in the
lung including epithelial cells, endothelial cells, mesenchymal
cells, and leukocytes (Chen et al., 2012; Jain et al., 2015; Lechner
et al., 2017; Rafii et al., 2015). In this model, a small number of
cells expressing Hopx+, amarker for the AT1 lineage, were found
to both proliferate and, in rare instances, give rise to Sftpc+ AT2
cells (Jain et al., 2015). A recent study revealed heterogeneity
within the AT1 cell population where expression of Igfbp2
marked the most mature AT1 cell subtype that lacks differentia-
tion capacity following pneumonectomy (Wang et al., 2018).
Although cells expressing AT1 markers proliferate during
compensatory lung growth after partial pneumonectomy,
whether bona fide AT1 cells are able to contribute to repair after
acute lung injury is largely unknown.
Alveolar Endothelial Response to Injury. Effective gas ex-
change is dependent upon AT1 cell and pulmonary capillary
endothelial cell (PCEC) proximity, and successful alveolar regen-
eration requires re-establishment of this spatial relationship.
Following lung injury in rodents, there is rapid proliferation in
the microvasculature, with expansion of resident microvascular
endothelial progenitor cells (Alvarez et al., 2008). These cells
are marked by Cd34 and Cd309, and in organoid culture demon-
strate significant vasculogenic capacity. While both the mecha-
nisms of PCEC regeneration and cellular identities within this
compartment are incompletely understood, endothelial cells ex-
pressing Sox17 have recently been shown to play a role in endo-
thelial regeneration after endotoxic-induced vascular injury (Liu
et al., 2019a). Additionally, PCECs enhance alveologenesis
following injury, with PCEC-derived Vegfr2 and Fgfr1 mediating
epithelial proliferation (Ding et al., 2011). This signaling is thought
to be through MMP14, and possibly co-mediated through484 Cell Stem Cell 26, April 2, 2020platelet activation of endothelial SDF-1 receptors (Rafii et al.,
2015). Significant additional heterogeneity is thought to exist
within the distal lung endothelium, with differential vasculogenic
capacities and crosstalk with the epithelium (Stevens et al.,
2008), and this has recently been revealed in single-cell tran-
scriptomic studies of the homeostatic lung and its response to
acute injury (Niethamer et al., 2020). This study demonstrated
the presence of multiple microvascular endothelial subsets
including one which expresses high levels of Car4 and Cd34.
This study also showed that a population of proliferating endo-
thelial cells emerges soon after influenza injury and single-cell in-
formatic trajectory analysis suggests that these cells arise from
multiple endothelial subsets. Future work is needed to define
the functional role for these endothelial subsets in both normal
alveolar homeostasis and the response to injury.
Alveolar Mesenchymal Response to Injury. The lung alveolus is
also home to a complex mixture of mesenchymal cell types,
many of which are in close physical association with both alve-
olar epithelial and endothelial cells and play an active role in alve-
olar epithelial regeneration. Pioneering electron microscopy
studies demonstrated direct and extensive contacts between
lung fibroblasts and AT2 cells (Sirianni et al., 2003; Walker
et al., 1995). Mesenchymal cells expressing the platelet-derived
growth factor alpha (Pdgfra) are often found in close association
with AT2 cells (Barkauskas et al., 2013; Green et al., 2016; Zepp
et al., 2017). The first functional evidence of trophic interactions
between these populations was the observation that Pdgfra+ fi-
broblasts support the growth and differentiation of AT2s in an
alveolar organoid co-culture assay (Barkauskas et al., 2013).
Alveolar organoids have been recently used to provide functional
evidence that multiple signaling pathways originate in Pdgfra+
cells to influence AT2 cell self-renewal and differentiation into
AT1 cells including Fgf7, Bmp, and Il6 (Chung et al., 2018; Green
et al., 2016; Zepp et al., 2017). As molecular techniques have
evolved, an emerging literature has revealedmolecular and func-
tional heterogeneity of lung alveolar mesenchymal cells. In
particular, accumulating data demonstrate the previously under-
appreciated heterogeneity of cells within the Pdgfra+ population
of fibroblasts in the adult (Green et al., 2016; Zepp et al., 2017).
Single-cell transcriptome analysis combined with spatial dis-
tance mapping recently demonstrated that one subpopulation
of fibroblasts, defined by the co-expression of Axin2 and Pdgfra,
is localized particularly close to AT2 cells and provides signals
including Il6, Fgfs, and Bmp antagonists that promote the self-
renewal and differentiation of AT2s (Zepp et al., 2017). This fibro-
blast population has been named the mesenchymal alveolar
niche cell or MANC and these cells are thought to have a critical
role in homeostatic alveolar regeneration following injury (Zepp
et al., 2017).
Immune Response to Alveolar Injury. Resident and circulating
leukocytes are thought to also play a critical role in alveolar repair
and regeneration, with elegant in vivo and in vitro studies demon-
strating that ‘‘inflammatory’’ cytokines have direct effects on the
proliferation and differentiation of both airway and alveolar
epithelial cells (Danahay et al., 2015; Katsura et al., 2019; Kuper-
man et al., 2002; Tadokoro et al., 2014; Xie et al., 2018). How-
ever, our understanding of the interactions between alveolar
epithelial cells and resident or circulating leukocytes is in its in-
fancy. Macrophages, the primary resident immune cell of the
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development (Tan and Krasnow, 2016). LPS stimulation of these
early resident macrophages leads to impaired branching
morphogenesis, attributed to changes in integrin, Bmp, and
Wnt signaling (Blackwell et al., 2011). Whether unstimulated resi-
dent macrophages have a normal role in branching morphogen-
esis or the differentiation of alveolar epithelial cells remains to be
elucidated. However, there are multiple lines of evidence indi-
cating that leukocytes play important roles in adult alveolar
regeneration, mediated at least in part through bidirectional
intercellular communication with alveolar epithelial cells. For
example, following either chemical or infectious lung injury, resi-
dent alveolar macrophages can stimulate epithelial proliferation
through the production of Wnt ligands (Hung et al., 2019). A sub-
set of alveolar macrophages can also act as memory macro-
phages and help guide the rapid activation of multiple chemo-
kines including those that stimulate neutrophils (Yao et al., 2018).
Compensatory lung growth after partial pneumonectomy pro-
vides a relatively simple model to study pro-regenerative epithe-
lial-immune interactions without the confounding effects of
infection and inflammation. This model was used to demonstrate
that platelets can initiate a regenerative cascade by secreting
SDF1 after pneumonectomy. This stimulates capillary endothe-
lial cells to express MMP14, releasing EGF ligands from the
extracellular matrix and subsequently promoting AT2 cell prolif-
eration and differentiation (Rafii et al., 2015).
Following partial pneumonectomy, local production of the
chemokine CCL2 leads to the recruitment of CCR2+ monocytes
to the lung (Lechner et al., 2017). These monocytes and resident
macrophages can be polarized by IL13 that is secreted by type 2
innate lymphoid cells, and loss of this axis impairs optimal
compensatory lung growth after pneumonectomy. Data from
an in vitro co-culture assay suggest that macrophages can
directly modulate AT2 cell survival and self-renewal (Lechner
et al., 2017). Recruited CCR2+ monocytes have also been impli-
cated in dysplastic alveolar repair following both bleomycin-
induced lung injury and other models of lung fibrosis (Misharin
et al., 2017; Venosa et al., 2019). These studies highlight the
context-dependent roles of CCR2+ monocytes in both normal
and abnormal lung regeneration.
In infectious andmore destructive lung injury models, it can be
difficult to discern the inflammatory roles of leukocytes from
regenerative roles, if such a distinction exists. Nevertheless,
data from a growing number of contexts have shown that resi-
dent and recruited immune cells are essential for resolution of
lung injury. For example, the depletion of macrophages during
the resolution phase of bleomycin-induced lung injury prolonged
the fibrotic response and impaired resolution (Gibbons et al.,
2011). This effect was attributed to a decrease in the clearance
of accumulated extracellular matrix but could also involve dis-
rupted communication with epithelial progenitor cells or other
populations.
Other immune populations are activated or recruited to the
alveolar niche following lung injury. We have nascent under-
standings of the inflammatory cellular diversity and intercellular
communications that determine normal versus abnormal lung
regeneration in response to lung injury. Understanding this
diversity and improving model systems, including more precise
animal models and organoid and lung-on-a-chip models thatincorporate immune cells, will allow us to study the contributions
of immune cell communications that drive lung repair (Gkatzis
et al., 2018).
Airway Regeneration
Maintenance and Regeneration of the Proximal Airway Epithe-
lium. The proximal airways in mice and humans are exposed to
frequent insults from the environment and serve as the first line
of immune and toxin defense in the lung, warming and filtering
the air as it passes tomore distal regions. Much of what is under-
stood about airway regeneration comes from studies of the
mouse trachea, which most closely resembles the structure of
human proximal airways. There are many parallels between the
murine trachea and the human intrapulmonary airways, with
the most relevant for this discussion being the presence of basal
cells. In mice, basal cells reside in the trachea and proximal main
stem bronchi; however, in humans this population extends for
several airway generations (Figures 1 and 2). Murine intrapulmo-
nary airways are not pseudostratified and do not contain basal
cells which are the primary stem cell population in human air-
ways. Thus, intrapulmonary mouse airways should not be used
as amodel system for the study of human airways. The pseudos-
tratified upper airway and tracheal epithelium exhibits very slow
turnover during health but several of the mature lineages are
capable of re-entering the cell cycle to replenish loss of neigh-
boring cells and maintain an epithelial barrier. Basal cells in the
proximal airways are the major stem cell population that self-
renew and when necessary give rise to multiple cell types such
as secretory, goblet, and multi-ciliated cells (Figure 2; Hegab
et al., 2012; Hong et al., 2004; Rock et al., 2009, 2011). This pro-
cess is critical for both maintenance and cellular regeneration af-
ter significant injury and is controlled by Notch signaling (Mori
et al., 2015; Rock et al., 2011; Ruiz Garcı´a et al., 2019; Stupnikov
et al., 2019). Although it was once thought that basal cells were a
rather homogeneous population, recent findings reveal more
complexity and have demonstrated their early origins in develop-
ment (Yang et al., 2018). Careful lineage tracing of cytokeratin 5
(Krt5) basal cells over time indicated that at least two populations
of basal cells exist in the upper airway, with one acting more as a
self-renewing stem cell, and the other committed to luminal dif-
ferentiation (Watson et al., 2015). Consistent with this paradigm,
depending on enhanced Notch2 signaling or c-myb expression,
basal stem cells directly give rise to secretory cells or multi-cili-
ated cells, respectively (Pardo-Saganta et al., 2015).
Recent studies have uncovered additional complexity within
the pseudostratified airway epithelium of mouse trachea and
human large airway, with the description of new, rare cell types
including CFTR-rich ionocytes (Montoro et al., 2018; Plas-
schaert et al., 2018). Multiple studies using lineage tracing anal-
ysis combined with single-cell transcriptomic work confirmed
that the Krt5 basal cell population was capable of giving rise
to all the observed cell types within the airway, including the
newly identified ionocyte, and other rare epithelial cell subsets
such as the tuft cell, which is not normally present in uninjured
mouse airways (Montoro et al., 2018; Mori et al., 2015; Rane
et al., 2019; Rock et al., 2011; Ruiz Garcı´a et al., 2019). More-
over, tuft cells, also known as solitary chemosensory cells,
ectopically emerge after influenza injury in the mouse and
may play a role in post-injury dysplastic remodeling of the
lung (Rane et al., 2019). Some of these lineage relationshipsCell Stem Cell 26, April 2, 2020 485
Large airway, pseudostratified epithelium
Neuroendocrine cellMulticiliated cell Ionocyte
Variant club cell 
Submucosal gland
myoepithelial cell 
Basal cell Club cell
H2-K1high
progenitors
Bronchioalveolar 
stem cell (BASC)
Small airway, columnar surface epithelium
Submucosal gland
Tuft/brush cellLuminal cell 
Alveoli 
Figure 2. Airway Cell Lineages Involved in Lung Repair and Regeneration
Structure of the pseudostratified large airways and trachea of the mouse lung showing submucosal glands which are lined with both myoepithelial cells and other
luminal secretory lineages. The smaller airways of the mouse lung contain various luminal secretory and ciliated epithelial lineages as shown. Some of these
including the BASCs and the H2-K1high secretory cell subtypes have been proposed to generate alveolar epithelium after severe injury.
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ture, highlighting the shared regenerative potential across spe-
cies (Rock et al., 2009).
While basal cells are a main driver of regeneration after airway
injury, other cell types have been shown to contribute as faculta-
tive progenitors. Lineage tracing analysis of airway Scgb1a1+
cells revealed that secretory cells proliferate to help maintain
the club cell population (Figure 2; Rawlins et al., 2009; Van Key-
meulen and Blanpain, 2012) and are a major source of multi-cili-
ated cells in normal airways, particularly in themore distal murine
airways where basal cells are not typically found. In addition,
subsets of secretory cells expressing Upk3a in mice, so-called
variant-club cells, have been shown to be localized near neuro-
endocrine bodies, suggesting a possible niche, and are capable
of giving rise to both secretory and ciliated cells in development;
however, a role in the response to injury is not yet clear (Guha
et al., 2012, 2017). Additionally, neuroendocrine (NE) cells also
can function as facultative progenitors after airway injury,
interact with immune lineages during expansion, andmay harbor
sublineages with enhanced progenitor capacity in NE bodies
(Branchfield et al., 2016; Garg et al., 2019; Ouadah et al.,
2019). In extreme situations, mature secretory/club cells (defined
by Scgb1a1 expression) have been reported to dedifferentiate in
the setting of marked basal cell loss, and contribute to the basal
stem cell pool, although the homeostatic or physiologic role of
this in injury is not clear (Tata et al., 2013). In addition, a novel
pathway of basal cell repletion from the submucosal gland was
also reported by two different groups using lineage tracing and
multiple airway injury models (Lynch et al., 2018; Tata et al.,
2018). These investigators found migration of glandular myoepi-
thelial cells into the airways with subsequent differentiation to
mature airway lineages including basal cells.486 Cell Stem Cell 26, April 2, 2020Regeneration of Distal Airway Epithelium after Injury. A num-
ber of distinct, small populations of progenitor cell types have
been reported to contribute to regeneration of distal airway
epithelia after injury in mice, which lacks basal cells (Barkaus-
kas et al., 2013; Bertoncello and McQualter, 2010; Chen,
2017; Perl et al., 2005). One of the first was a variant club/
secretory cell (v-club cells) defined by its location near neuro-
endocrine bodies and low cytochrome Cyp2f2 expression,
making these cells resistant to naphthalene injury and thus a
source of regenerative cells after this injury (Giangreco
et al., 2009; Hong et al., 2001). More recently Upk3a was iden-
tified as a unique marker for v-club cells. A Upk3acreER lineage
trace (Guha et al., 2017) demonstrated that these cells give
rise to club cells and ciliated cells during homeostasis and af-
ter naphthalene airway injury, as predicted from prior studies
(Giangreco et al., 2009; Hong et al., 2001; Volckaert et al.,
2011). Although seemingly limited, in these studies some v-
club/secretory cells were also noted to differentiate into AT2
cells during bleomycin-induced alveolar injury, implying a ca-
pacity for mobilization and distal migration.
A second small population of stem/progenitor cells was iden-
tified at the branch point between distal murine airways and alve-
olus and was termed bronchoalveolar stem cells (BASCs).
BASCs were initially characterized by dual expression of the
secretory cell marker Scgb1a1 and the AT2 marker Sftpc by im-
munostaining and their localization at the bronchioalveolar duct
junction (BADJ) (Kim et al., 2005). Stem cell antigen-1 (Sca1) was
also proposed as a marker for these cells and has been used in
flow cytometry to purify these cells for in vitro culture studies
(Raiser and Kim, 2009). Recently, intersectional-genetic lineage
tracing techniques allowed for the specific tracing of BASCs
and confirmed that BASCs can generate distal airway club cells
Cell Stem Cell
Reviewafter naphthalene injury and peri-junctional AT2 alveolar cells af-
ter bleomycin injury or influenza injury (Liu et al., 2019b; Salwig
et al., 2019). One of the limitations of these studies is the use
of Scgb1a1 expression to mark BASCs, as this gene and protein
are known to be expressed in a subset of AT2 cells, which could
confound such lineage tracing (Rawlins et al., 2009). While the
genetic depletion of the BASC population resulted in a delay of
the murine regenerative response to injury, full regeneration
was eventually observed, suggesting that BASCs are not abso-
lutely required for lung regeneration.
An additional distal airway stem/progenitor cell population
with regenerative potential was identified descriptively as line-
age-negative epithelial progenitors (LNEPs), also referred to as
distal airway stem cells (DASCs). These cells are distinct from
v-club/secretory cells and BASCs. LNEPs were originally
defined as distal airway integrin b4+/CD200+ cells without
discernible mature lineage markers by protein immunostaining
(Vaughan et al., 2015). These cells are also Sox2+, as expected
for an airway epithelial cell. Subsequently it became apparent
that LNEPs/DASCs are composed of both Trp63+ cells and
Trp63 cells. The Trp63+ cells appear to be holdovers from em-
bryonic Trp63+ basal cells and some 20% of these cells could be
traced with the Scgb1a1creER mouse line (Yang et al., 2018).
Although true basal cells are not normally found in the distal
mouse airway, the rare Krt5+/Trp63+ LNEPs/DASCs expand
and mobilize after influenza injury to generate collections (or
pods) of Krt5+ basal-like cells throughout the heavily damaged
areas of influenza-injured mice (Vaughan et al., 2015; Xi et al.,
2017; Zuo et al., 2015). This mobilization is initially protective to
the mouse but ultimately is a dysplastic response as Krt5+ basal
cells have limited potential to differentiate into AT2 cells and the
mouse becomes permanently burdened with airway-like cystic
structures throughout the alveolar compartment. Appearance
of these permanent cystic structures was linked with activated
Notch signaling, and blockade of hypoxemia response via dele-
tion of hypoxia inducible factor 1 (HIF1a) in airway cells promotes
the contribution of airway cells to regeneration of AT2s and sub-
sequent improvement in oxygen saturation (Xi et al., 2017).
Contribution of Distal Airway Progenitors to Alveolar Repair.
Although endogenous AT2s represent the primary regenerative
responders to various alveolar insults and regenerate the over-
whelming number of new AT2 and AT1 cells after limited alveolar
damage, several lines of evidence implicate activation of distal
airway epithelial cells as an alternative source of alveolar epithe-
lial cells following certain types of severe lung injury (Barkauskas
et al., 2013; Chapman et al., 2011; Xi et al., 2017). Recently, rare
MHChigh (H2-K1high) club cell-like progenitors have been
described within the larger Scgb1a1 lineage-traced population
of all lung cells. These cells have proliferative capacity, appear
to give rise to AT2 and AT1 cells following bleomycin-induced
lung injury, and can be purified by flow cytometry using anti-
H2-K1 antibodies (Kathiriya et al., 2020). H2-K1high cells are a
subpopulation of b4/CD200 cells, express low or no mature
lung epithelial lineage markers (e.g., Scgb1a1 or Sftpc) at the
protein level, and represent 5% of all Scgb1a1CreER-labeled
lung cells, but exhibit clonogenic potential to generate these
broader populations in cell culture outgrowth assays (Kathiriya
et al., 2020). H2-K1high cells were found to survive and differen-
tiate into AT2 and AT1 cells in vivo after intra-airway transplanta-tion into bleomycin-injured mice. These cells were also found to
be specifically targeted by H1N1 PR8 influenza virus, consistent
with a prior report showing b4+/CD200+ cells as a primary target
of the viral injury (Quantius et al., 2016). The alveolar epithelial dif-
ferentiation capacity of H2-K1high progenitors after bleomycin
injury contrasts sharply with the differentiation repertoire of the
rare Trp63+ cells which predominantly gives rise to dysplastic
Krt5+ pods, but virtually no alveolar epithelial cells (Ray et al.,
2016; Vaughan et al., 2015; Xi et al., 2017). Additional studies
combining injury models with modern cell lineage tracking tech-
niques and single-cell analysis are needed to clarify the injury-
specific activation of airway cells and their relative contributions
toward alveolar regeneration. Importantly, whether BASCs,
LNEPs, and H2-K1high progenitors represent similar or overlap-
ping populations of cells remains unclear. Future studies will
need to directly compare these distal airway cells to the resident
AT2 and AEP cell populations, to more fully assess their ability to
repair and regenerate the alveolar niche after acute injury and in
chronic diseases.
Contribution of the Mesenchyme to Airway Regeneration. A
series of complex and interconnected interactions are em-
ployed to maintain distal airway epithelium during quiescence
and after injury within the local niche. The local niche is
comprised of the extracellular matrix (ECM) and several mesen-
chymal cell types. Specifically, the mesenchyme plays a critical
role in function of distal airway epithelium by providing a num-
ber of signaling cues that ultimately determines the stem cell
response during injury. Much of what is known about the inter-
play in adults between the mesenchyme and the epithelium has
been derived from studying lung development. These develop-
mental signaling pathways include Wnt/b-Catenin, fibroblast
growth factor 10 and its receptor Fgfr2 (Fgf10/Fgfr), retinoic
acid, and sonic hedgehog (Shh) members of transforming
growth factor b (Tgfb) superfamily including bone morphoge-
netic proteins (Bmp), Hippo/Yes-associated protein (YAP),
and Notch signaling. For example, airway smooth muscle cells
promote epithelial repair through the production of Fgf10 (Lee
et al., 2017; Volckaert et al., 2011) and a population of Pdgfra+
fibroblasts promote the differentiation of multi-ciliated cells
through the production of Il6 (Tadokoro et al., 2014). In addition
to signaling to the airway epithelium during regeneration, the
airway mesenchyme can undergo a phenotypic change
following injury that drives abnormal regeneration. A recently
identified mesenchymal subpopulation identified by Axin2
expression but lacking Pdgfra expression, the Axin2+ Myogenic
Progenitor or AMP, becomes activated after naphthalene
airway injury, begins to express Acta2, and contributes the
airway fibrosis in the naphthalene model (Zepp et al., 2017).
A more thorough review on these pathways and their cell-spe-
cific functions can be found elsewhere (Kotton and Morrisey,
2014; Leach and Morrisey, 2018; Lee and Rawlins, 2018;
Zepp and Morrisey, 2019).
Human versus Mouse Lung Repair and Regeneration
The human lung contains many structural and anatomic differ-
enceswhichmake it unique from itsmurine counterpart. Themu-
rine lung has a 6,000-fold smaller tidal volume, an 8,000 times
smaller surface area, and roughly half the generations of airways
compared to its human counterpart (Irvin and Bates, 2003; Knust
et al., 2009; Thurlbeck, 1967). This significant difference in organCell Stem Cell 26, April 2, 2020 487
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tion, and gas exchange. These differences highlight the critical
variances that need to be accounted for as the field moves
from bench to bedside.
The alveolus is one of the most architecturally conserved re-
gions between the murine and human lung (Figure 1). Conserva-
tion of the cellular populations between mouse and human
alveoli have been demonstrated through multiple techniques
and include the above-described AT1 andAT2 epithelial lineages
and the AEP sublineage. Furthermore, the regenerative capacity
of the alveolus appears to be retained across species, as dis-
cussed above.
The cellular anatomy of trachea and the most proximal air-
ways in mice and the large airways in humans is very similar.
The cells of the murine trachea and their progenitor and regen-
eration capacity appear to be closely aligned with in vitro
models of human proximal airway regeneration. However, the
distal conducting airway anatomy of the mouse is quite
different from humans. In mice, the intrapulmonary airways
are almost completely devoid of cartilaginous rings, bronchial
blood support, submucosal glands, and pseudostratified
epithelium, all of which is in direct contrast to their human
counterparts. Furthermore, murine conducting airways termi-
nate directly into alveolar sacs at the site of the BADJ. Humans
do not have a BADJ, and instead have a distinct distal airway
compartment which includes the respiratory bronchioles. These
distal respiratory bronchioles are interdigitated with alveolar-
like structures that leads into the larger alveolar compartment.
There is no analogous counterpart to the human respiratory
bronchioles in mice. Terminal and respiratory bronchioles in hu-
mans contain Krt5+ basal cells that are generally absent in the
distal airways of mice. To date, a BASC-like cell population has
not been found in humans, perhaps due to the lack of the cor-
responding BADJ anatomical niche. Thus, the cellular origins of
distal airway repair and the origin of airway-based stem/pro-
genitors mobilized during alveolar injury in humans are likely
different from that of mice. Given the significant differences be-
tween the human and mouse lung, especially in the distal
airways, greater focus is needed to study the human lung,
both through descriptive assessment using new techniques
including single-cell analysis as well as more sophisticated as-
says including organoids, ex vivo lung explants, and pluripotent
stem cell-derived human lung lineages.
Pulmonary Fibrosis
Idiopathic pulmonary fibrosis (IPF) is the most common adult
interstitial lung disease (ILD), a class of pulmonary diseases
pathologically defined by interstitial fibrosis, inflammation, or
the combination of fibrosis and inflammation (Lederer and Mar-
tinez, 2018). A recognized theory of IPF pathogenesis places
the initial site of ‘‘micro-injury’’ in the alveolar space with the
AT2 cell holding an important position in disease development.
Recent transcriptional interrogation of the distal epithelium in
IPF identified activation of cell stress and senescence pathways,
and murine modeling of AT2 cell dysfunction from expression of
either mutant SFTPC, loss of telomere function, and increased
mechanical tension have provided in vivo proof of concept that
disruption of AT2 cell homeostasis is a driver of lung fibrosis
(Katzen et al., 2019; Naikawadi et al., 2016; Nureki et al., 2018;
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dysfunctional AT2 cell loses its facultative progenitor capacity
creating a regenerative void for lung repair. In support of this hy-
pothesis, a cardinal feature of the pathobiology of IPF is bron-
chiolization, a term coined decades ago to codify the observa-
tion by chest pathologists that epithelial cells with airway
markers accumulate in the fibrotic regions of human lungs, ap-
pearing to extend the junctional region between distal airways
and remaining alveoli (Chilosi et al., 2002). Micro-honeycomb
cysts, another cardinal feature of fibrotic remodeling in humans,
are mainly lined by epithelial cells with airway markers, including
basal, goblet, and ciliated markers (Seibold et al., 2013). The
realization that distal airway stem/progenitors robustly mobilize
in mice to occupy alveolar surfaces suggests a parallel process
in humans. While potentially protective against loss of tissue
integrity, the progenitors arising from distal airways are also sub-
ject to signals that direct their differentiation to airway rather than
alveolar phenotypes. These include hypoxia and Notch signaling
(Chen, 2017). Once differentiated to airways cells, differentiation
to normal AT2 or AT1 cells may be very difficult and inefficient,
potentially accounting for the dysplastic structures that domi-
nate the pathobiology of lung fibrosis (Kumar et al., 2011;
Vaughan et al., 2015). In this paradigm, the dysplastic epithelial
cysts accumulating progressively in fibrotic human lungs repre-
sent remnants of failed repair, as discussed above. Future efforts
to both better understand the development of AT2 cell progeni-
tor dysfunction and to minimize the pathway of airway differenti-
ation of activated progenitors within alveoli of humans could be
therapeutic.
Chronic Obstructive Pulmonary Disease
Chronic obstructive pulmonary disease (COPD) is a leading
cause of morbidity and mortality worldwide, and prevalence
continues to increase across the globe with the continued rise
in cigarette use and toxic biomasses (Burney et al., 2015). In
contrast to IPF, which is characterized by robust cellular produc-
tion at the site of injury resulting in a dysplastic, fibrotic pulmo-
nary parenchyma, the cardinal feature of COPD in the alveolar
space is cellular loss and alveolar simplification, known as
emphysema.Mechanistic studies in COPD, however, have failed
to generate novel therapeutics aimed at actual lung regen-
eration.
While much of the work on the deleterious effects of toxin ex-
posures on airway cells has been done in bronchial or upper
airway cells, careful anatomic studies have suggested that the
site of obstruction is localized to the distal airways and in partic-
ular the respiratory airways (McDonough et al., 2011; Koo et al.,
2018). The cellular structure and composition of the distal airway
region of the human respiratory system, in particular the respira-
tory bronchioles, is poorly understood. The final endpoint of
emphysema, however, is marked by loss of the alveolar epithe-
lium, which can be studied in murine models. Studies have
pointed to an increase in senescence in AT2 cells and the asso-
ciated endothelium as a mechanism for the development of
COPD in certain patient populations and the increased preva-
lence of the disease with aging (Gao et al., 2017). Together
with the presence of increased senescence in lung fibroblasts
from patients with COPD, these studies may suggest an ex-
hausted phenotype in a final common pathway downstream of
repeated alveolar repair in the setting of recurring toxic exposure
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Figure 3. A Schematic of the Directed Differentiation of hiPSCs to Lung Epithelial Cells
The key signaling factors and the main stages of the in vitro derivation of lung epithelial cells are provided. Following lung specification, late withdrawal of CHIR
gives rise to mature AT2 cells (dark red). Early withdrawal of CHIR gives rise to airway progenitors (light blue) or a mixture of mature airway cells (dark blue) and
AT2 cells, depending on the protocol used.
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repair has been associated with reduced Wnt signaling in the
COPD microenvironment, and this defective response has
been suggested to be downstream of a shift in canonical to non-
canonical Wnt signaling in the presence of toxic stimuli such as
cigarette smoke (Baarsma et al., 2017). Whether this change in
Wnt signaling is associated with an aberrant or absent response
by the Wnt-responsive AEP sublineage in the AT2 cell popula-
tion, remains unclear. More work is needed to understand how
toxic injuries incite distal epithelial cell responses in COPD, in or-
der to be able to develop therapies aimed at bona fide repair of
the alveolus, and therefore clinical improvement.
Tools and Techniques to Study Human Lung
Regeneration
Deriving Lung Epithelium De Novo via Directed
Differentiation of ESCs/iPSCs
The fact that most types of primary lung epithelial cells have been
difficult to propagate as stable phenotypes in cell culture has
raised significant hurdles for performing basic mechanistic
studies in vitro for human lung lineages. A potential solution to
these challenges has emerged with the discovery of techniques
to differentiate pluripotent stemcells (PSCs) in vitro into a diversity
of lung lineages. Embryonic stem cells (ESCs) and their engi-
neered equivalents—induced pluripotent stem cells (iPSCs)—
represent the gold standards of PSCs, and a rapidly emerging
literature has gradually led to successful methods for controlling
their differentiation in cell culture.
Directed Differentiation of Pluripotent Stem Cells. The in vitro
differentiation of either ESCs or iPSCs into specific tissue line-
ages can be guided by adding combinations of growth factors
or small molecules to media at specific times during culture
(Figure 3), in order to recapitulate the signaling pathways that
regulate in vivo organ development (Murry and Keller, 2008).
The process of recapitulating development in vitro to sequen-
tially pattern pluripotent stem cells toward desired fates is
termed ‘‘directed differentiation’’ and has been successfully
applied for deriving multiple cell types from ESCs/iPSCs,
including lung epithelia (Huang et al., 2015). To date most ofthe cell types produced from ESC/iPSC have an immature
phenotype and are not yet ready for clinical applications.
Initial attempts at deriving lung epithelium from PSCs were
inefficient, stochastic, used incompletely defined media, or
relied on the presence of drug-resistance genes (Coraux et al.,
2005; Van Haute et al., 2009; Wang et al., 2007). The difficulty
in part was due to a lack of information regarding normal lung
development in vivo. As basic mechanisms were discovered
that regulate the formation of definitive endoderm, an ability to
derive lung epithelia from PSCs in vitro via sequential differenti-
ation into definitive endoderm and subsequent patterning into
foregut endoderm followed (Green et al., 2011; Kubo et al.,
2004). The most successful of these strategies to date has
involved the exogenous addition of growth factors and inhibitors
at specific times and concentrations to mimic the progressive
cell signaling between the endoderm andmesoderm that specify
definitive endoderm, pattern the endoderm anteriorly and then
ventrally, ultimately inducing Nkx2-1+ respiratory progenitors
that differentiate into lung epithelium (Green et al., 2011; Long-
mire et al., 2012; Mou et al., 2012; Rankin et al., 2016). A variety
of studies to date indicate that the key step of initial specification
of the lung epithelial lineage from foregut endodermal precursors
generated from PSCs in vitro can be monitored by assessing the
kinetics and efficiency of expression of Nkx2-1 or reporters for
this locus (Gotoh et al., 2014; Green et al., 2011; Longmire
et al., 2012; Mou et al., 2012; Rankin et al., 2016). These studies
indicate that lineage specification requires the precise temporal
activation of Wnt, BMP, and RA signaling (Huang et al., 2014;
Rankin et al., 2016; Serra et al., 2017).
Although a high degree of agreement exists on strategies to
generate lung-specified anterior foregut endoderm (AFE), the
generation of mature lineages is less straightforward. Similar to
other organs and tissues, the generation of fully mature cells re-
mains challenging and is a major limitation to the application of
human PSC-derived cells for disease modeling and regenerative
medicine (Lancaster and Knoblich, 2014). Nevertheless, sub-
stantial progress has been made in recent years and some guid-
ing principles have emerged. In initial studies, differentiation of
PSC-derived lung progenitors was performed in adherent 2DCell Stem Cell 26, April 2, 2020 489
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and human (Firth et al., 2014; Huang et al., 2014, 2015; Mou
et al., 2012). This led to cultures containing a mixture of cells of
undetermined maturity, but including cells expressing markers
of AT2 cells. However, expression of SFTPC, one of the most
specific markers of AT2 cells, was sparse. Culture of the same
cells on thin slices of human decellularized lung matrix induced
strong expression of SFTPC, suggesting that SFPTC expression
and hence emergence of AT2 cells was facilitated by a 3D envi-
ronment (Huang et al., 2014). Furthermore, cultures in 3D condi-
tions, typically Matrigel, induced SFTPC expression accompa-
nied by emergence of a mature AT2 program that includes
production of surfactant proteins and phospholipid (Gotoh
et al., 2014; Jacob et al., 2017; Yamamoto et al., 2017). Culture
systems have nowbeen developedwhere AT2 cells can be prop-
agated as spheroids in 3D Matrigel cultures in presence and
absence of feeders consisting of pulmonary fibroblasts (Jacob
et al., 2017; Yamamoto et al., 2017). Similarly, airway progenitors
generated from developmental lung progenitors specified to an
anterior fate can be grown as epithelial spheres containing cili-
ated and secretory cells in 3D cultures (Konishi et al., 2016;
McCauley et al., 2017). Single-cell RNA sequencing profiles of
these spheres (McCauley et al., 2018) has confirmed the deriva-
tion of airway lineages, but has also raised a cautionary note as
non-lung endodermal lineages (e.g., hepatic or gut epithelia) also
appear within these spheres over extensive culture periods, rep-
resenting an ongoing challenge to the field.
Further efforts have resulted in the generation of more com-
plex lung organoids from PSCs. Lung organoids grown in Matri-
gel droplets can generate airway structures after xenografting
into mice, while the bud tip organoids could only generate small
pockets of ciliated cells after transplantation into naphthalene-
injured lungs of immunodeficient mice (Dye et al., 2015, 2016;
Miller et al., 2018, 2019). In a second model, PSC-derived ante-
rior foregut endoderm cells were grown in suspension culture
and as spheres containing respiratory endoderm, and the endo-
dermal cells expressed sonic hedgehog (SHH), while the mesen-
chymal component expressed SHH targets. These organoids
were termed lung bud organoids (Chen et al., 2017). Most of
the cell types in these PSC lung organoid assays have been
shown to consist of fetal stage cells, again illustrating the chal-
lenges associated with achieving full maturation (Chen et al.,
2017; Dye et al., 2015, 2016; Miller et al., 2018, 2019). The origin
of the mesenchymal cells that appear to co-develop along with
endoderm in these PSC lung organoid cultures to date remains
unclear.
The second emerging principle arising from experience with
iPSC models is a need to better understand the temporal devel-
opmental signaling pathways required for lung lineage specifica-
tion. For example, BMP inhibition is required for AFE specifica-
tion (Green et al., 2011). However, consistent with mouse
genetic models, subsequent BMP agonism promotes lung fate
from AFE (Huang et al., 2014; Longmire et al., 2012). An impor-
tant component for the differentiation of AT2 cells is dexameth-
asone, 8-bromo-cAMP, and isobutylmethylxanthine (DCI), FGF7
or 10, and Gsk3b agonism using the small molecule CHIR9902
(Huang et al., 2014, 2015; Longmire et al., 2012; Serra et al.,
2017; Yamamoto et al., 2017; Miller et al., 2018). Withdrawal of
Gsk3b inhibition, which results in reduced Wnt signaling,490 Cell Stem Cell 26, April 2, 2020appears to induce a proximal fate in lung progenitors (McCauley
et al., 2017). Conversely, maintenance of CHIR9902 in 2D cul-
tures and subsequent plating in 3D cultures in the presence of
CHIR9902 yielded AT2 spheroids that could be replated and
expanded for many passages (Jacob et al., 2017). Interestingly,
full morphological maturation accompanied by reduced prolifer-
ation of AT2 cells could be accomplished bywithdrawal of Gsk3b
inhibition in the 3D cultures (Jacob et al., 2017). In some 3D
models, withdrawal of CHIR9902 led to both proximal and distal
maturation, with the generation of NGFR+ postnatal basal cells,
AT2 cells, and cells expressingmarkers of AT1 cells (de Carvalho
et al., 2019). Gsk3b inhibition was also required to generate re-
newing distal tip progenitors (Miller et al., 2018). Together, these
studies indicate that further analysis of the temporal activation
and repression of Wnt signaling in driving lung endoderm fate
is needed. Importantly, Gsk3b integrates multiple inputs and af-
fects a wide variety of signaling pathways and cellular process,
and some of its effects may be independent ofWnt signaling (Pa-
tel andWoodgett, 2017). Additional signaling pathways including
Notch (Chen et al., 2017, 2019; Firth et al., 2014; McCauley et al.,
2017; Konishi et al., 2016) and retinoic acid are important for pro-
moting lung endoderm cell fate (Miller et al., 2018).
A third principle guiding effective directed differentiation of
PSCs into lung epithelium is the proper initial establishment of
lung progenitor fate. The purity of the PSC-derived lung progen-
itors, which can vary from line to line, remains a problem (Huang
et al., 2015). One solution is the use of reporters, such as fluoro-
chrome constructs targeted to NKX2.1, SFTPC, or SCGB3A2
loci, which allow flow cytometric purification of desired cell types
(Gotoh et al., 2014; Hawkins et al., 2017; McCauley et al., 2017,
2018; Serra et al., 2017). These cell lineage-specific reporters
have been useful in defining the differentiation strategies of
various cell types in the lung. However, a drawback of reporter
lines is that this strategy is unlikely to be approved for the purifi-
cation of human cells for clinical therapies. A second solution is
the use of surface markers to enrich for lung endoderm progen-
itors such as carboxypeptidase M or CD47hiCD26lo cells (Gotoh
et al., 2014; Hawkins et al., 2017; Korogi et al., 2019).
Lung Disease Modeling via Pluripotent Stem Cells. One of the
major applications for iPSC-derived lung epithelial lineages is
providing an in vitro platform for studying human pulmonary dis-
eases. Early applications of iPSCs attempted to model cystic
fibrosis (CF), a disease caused bymutations in the anion channel
protein, CFTR (cystic fibrosis transmembrane conductance
regulator), which leads to progressive lung damage due to
impairedmucociliary clearance, inflammation, and recurrent res-
piratory infections. Wong et al. (2012) developed the first iPSC-
derived model of CF using a 2D system in which CF-iPSC-
derived epithelial cells exhibited lower CFTR expression and
reduced anion transport in response to forskolin, a known
CFTR activator. A subsequent 2D airway model was published
by Firth et al. (2014), in which the authors demonstrated the pres-
ence of functional CFTR channels, with anion currents that could
be modulated by both forskolin and a CFTR inhibitor. CRISPR
correction of a CFTR mutation in iPSCs by two separate groups
then demonstrated an in vitro rescue of channel function (Crane
et al., 2015; Firth et al., 2015). Finally, recent work fromMcCauley
et al. (2017) used iPSC-derived airway epithelial spheres to
demonstrate that CRISPR correction of CFTR mutants can
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an easily visualized read-out for future high throughput screens
of airway CFTR function.
More recent applications of iPSC-derived lung models have
focused on a broad diversity of genetic lung diseases, lung can-
cer, or platforms for the study of viral respiratory infections. For
example, 2D differentiation of hPSC-derived lung progenitors al-
lowed modeling influenza susceptibility in iPSCs from a patient
with a genetic deficiency in IRF7 (Ciancanelli et al., 2015) and
from a patient with TLR3 mutation (Lim et al., 2019). The impor-
tance of these findings lies in the fact that they showed that not
only interferon production by immune cells was relevant to the
increased susceptibility of these patients to lethal influenza
infection, but that interferon production within distal lung epithe-
lial cells is likely involved as well. In branching 3D organoids, the
pathological changes associated with respiratory-syncytial vi-
rus-associated bronchiolitis could be reproduced (Chen et al.,
2017) and infection with clinical isolates of parainfluenza virus
could be modeled (Porotto et al., 2019). In 2D cultures, through
genetic manipulation of Rb and p53 expression in Notch-in-
hibited epithelium enriched in neuroendocrine cells, a human
in vitro model for small cell lung cancer was developed (Chen
et al., 2019). For modeling genetic diseases affecting the distal
lung, distal specification and generation of expandable AT2 cells
in 3D allowed modeling of SFTPB deficiency, which was cor-
rected by CRISPR/Cas9-mediated gene editing (Jacob et al.,
2017). Recessive mutations in some genes implicated in Her-
mansky-Pudlak syndrome (HPS) cause HPS-associated intersti-
tial pneumonia (HPSIP), a clinical entity similar to idiopathic pul-
monary fibrosis (Lederer and Martinez, 2018). Introduction of
HPSmutations associatedwith HPSIP in ESCs promoted fibrotic
changes in branching lung organoids (Chen et al., 2017), while
deletion of HPS8, which is not associated with HPSIP, did not
(Strikoudis et al., 2019). Further studies revealed an essential
role for IL11 in the fibrotic process, suggesting that IL11 is a po-
tential therapeutic target in this intractable disease (Strikoudis
et al., 2019). Additional work using AT2 cells generated from pa-
tient-specific iPSCs profiled the AT2 cell dysfunction that results
from HPS1 mutations (Korogi et al., 2019).
Cell-Based Therapy for the Respiratory System
Many false starts and claims of engraftment of exogenous cells
into injured murine lung tissue have confused the field for the
past 20 years, with an extensive literature emerging during
the controversial claims of bone marrow plasticity during the
1990s (reviewed in Kotton, 2012). More recently a few groups
have begun to publish more convincing evidence in support of
the capacity of epithelial stem/progenitor cells, of both mouse
and human origin, to survive in injuredmouse lungs after intratra-
cheal or intravenous delivery (Farrow et al., 2018; Miller et al.,
2018; Nichane et al., 2017; Rosen et al., 2015; Vaughan et al.,
2015). There is also recent evidence of more mature AT2 cells
of both mouse and human origin surviving transplantation into
injured mouse lungs (Hillel-Karniel et al., 2020; Weiner et al.,
2019). Whether these cells are functionally integrated into host
lung tissue, are long-lived, and retain expression of a complete
lung transcriptomic program are still open questions that will
need to be addressed before these cells can be referred to as
‘‘engrafted.’’ For example, only one study to date has attempted
to profile the transcriptomes of grafted cells at single-cell resolu-tion (Nichane et al., 2017). The use of lineage tracing techniques
and clonality studies are notably absent from most prior reports,
raising uncertainty about the cellular origins of the source cells
and preventing assessment of the stem cell properties of trans-
planted cells. Importantly, physiologic improvement of injured
mouse lungs after cell transplantation as described in some of
the above reports might be explained by paracrine effects or
transient secondary reparative effects on recipient lung tissue
rather than by direct, durable replacement of the epithelium
with functional cells. In addition to alveolar cell therapy, a recent
study demonstrated that it is possible to correct CF mutations
using primary airway basal cells, which could be used for
engraftment into patients (Vaidyanathan et al., 2020).
Many additional challenges remain in the translation of exper-
imental cell therapy in mice to humans with major lung injury,
including the issue of allogeneic rejection, possibly circum-
vented by the development of autologous, syngeneic iPSC-
derived stem/progenitors if these were to have engraftable po-
tential (Huang et al., 2015; McCauley et al., 2017; Miller et al.,
2018). The limitations listed above have also resulted in a dearth
of information regarding the mechanisms or microenvironmental
niche interactions that might regulate homing, survival, prolifera-
tion, or functional activation of potentially engrafted cells. More
sophisticated methods are needed to quantify the contributions
of exogenously delivered cells, relative to either endogenous
cells or competing alternative source cells. Additional studies
are needed to resolve the ongoing debate over which of many
candidate lung cell populations, from resident progenitors or
iPSC derivatives to common mature airway or alveolar cells,
might have the best relative potential to reconstitute an injured
epithelium after transplantation.
Single-Cell Genomic Analysis in Lung Biology
The extensive cellular heterogeneity within the respiratory sys-
tem and the lack of insight into the phenotype differences in
these purported cell lineages make single-cell genomics a very
useful tool in the study of lung repair and regeneration. This
spatial diversity in architecture and cellular heterogeneity rein-
forces the importance of sampling at multiple regions along the
respiratory airway axis to obtain a true cell atlas. Advances in
scRNA-seq techniques allow for prediction of cell state, origins,
and trajectories without requiring permanent genetic labeling of
cells. New tools enabling data analysis, visualization, and inter-
pretation are being developed at a rapid pace and are readily
available as ‘‘open source’’ tools. Likewise, data web portals
provide the research community with open access to rich diver-
sity of RNA, protein, and lipidomic and imaging data related to
the lung. Examples of this include the Lung Gene Expression
Atlas and BREATH databases (https://research.cchmc.org/
pbge/lunggens/mainportal.html and https://www.lungmap.net)
(Du et al., 2017). While time series of single-cell transcriptomic
data are most useful in identifying progenitor cells and their tra-
jectories, these processes can be identified in pseudotime using
data derived from a single time point when large numbers of cells
are in transition; for example, during organ formation, tissue
repair, or during active disease. Likewise, single-cell transcrip-
tomic data generated with embryonic stem cells or induced
pluripotent stem cells as they differentiate into distinct lung cell
types have provided new insights into the identity of lung cell
progenitors and the regulatory networks controlling cell fateCell Stem Cell 26, April 2, 2020 491
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et al., 2018; Nikolic et al., 2018).
Trajectory inference algorithms, or pseudotime analysis,
reconstruct continuous cell state transitions from ‘‘snapshots’’
of single-cell transcriptomic data, providing insights into gene
expression kinetics and regulatory dynamics of biological pro-
cesses (Gerber et al., 2018; Guo et al., 2017; Hawkins et al.,
2017). Wanderlust (Bendall et al., 2014), Monocle 1 (Trapnell
et al., 2014), Waterfall (Shin et al., 2015), and TSCAN (Ji and Ji,
2016) are among the early cell trajectory inference algorithms us-
ing scRNA-seq data. The general analytical workflow of a pseu-
dotime analysis algorithms includes (1) modeling individual cells
as data points in high-dimensional gene expression space,
where each dimension is defined by the expression of a gene;
(2) projecting cells onto a lower-dimensional space using a
dimension reduction method, e.g., principal component anal-
ysis, which finds a smaller set of new dimensions, each being
a combination of original input genes, to represent major vari-
ances in the original gene expression space, reduce noise, and
enable data visualization; (3) determining cell trajectories in the
reduced dimensional space; (4) ordering single cells by progress
along the cell trajectories; and (5) identifying gene expression
patterns along cell orderings.
With the evolution of single-cell technologies and exponential
growth in numbers of cells collected from single-cell experi-
ments (Svensson et al., 2018), scRNA-seq datasets have
captured complex cell trajectories that often contain multiple
cell type decision branches. Monocle 2 (Qiu et al., 2017), Wish-
bone (Setty et al., 2016), DPT (Haghverdi et al., 2016), SLICE
(Guo et al., 2017), Slingshot (Street et al., 2018), and URD (Farrell
et al., 2018) can be used to infer tree-structured cell trajectories
from scRNA-seq data, reconstructing branched cell transitional
paths from a progenitor toward multiple cell fates. To infer a
robust tree-structured cell lineage model, Slingshot (Street
et al., 2018) combines the use of multiple techniques recently
developed for processing highly noisy scRNA-seq data and al-
lows users to specify initial and terminal cells to supervise parts
of the tree construction, whichmight lead tomore accurate data-
specific lineage tree inference. Monocle 2 (Qiu et al., 2017) is a
comprehensive computational pipeline for scRNA-seq analysis,
including gene expression modeling, preprocessing, cell clus-
tering, differentiation expression analysis, and cell trajectory
inference analysis. Recently developed methods, including
PAGA (Wolf et al., 2019) and Monocle 3 (Cao et al., 2019), can
be used to infer more complex, non-tree-based cell trajectories.
Together with a number of implementation improvements in
computational efficiency and memory usage, PAGA and
Monocle 3 can be applied to infer complex lineage relations
from large scRNA-seq datasets with more than 1 million cells,
for example inferring the lineage relations of cells from a whole
adult animal (Plass et al., 2018) or the reconstruction of 10
disjointed major cell trajectories from1.5 million mouse embry-
onic cells during organogenesis (Cao et al., 2019).
Most of the trajectory inferencemethodspseudo-temporally or-
der cells purely based on transcriptomic similarity without esti-
mating cell states (e.g., differentiation states). They require the
use of external knowledge, such as time information, cell identity,
marker gene expression, or user inputs, to determine the start and
end points and the directions of inferred cell trajectories. StemID492 Cell Stem Cell 26, April 2, 2020(Gr€un et al., 2016), SLICE (Guo et al., 2017), and RNA Velocity
(La Manno et al., 2018) provide the capability to estimate cell dif-
ferentiation states, predicting progenitor cells and directions of
cell differentiation transitions. StemID (Gr€un et al., 2016) and
SLICE (Guo et al., 2017) both exploit the concept of entropy for
predictingcell differentiation states fromsingle-cell transcriptomic
profiles. RNA Velocity showed that scRNA-seq data can provide
not only static information on mRNA abundance of each gene in
a single cell but also dynamic information on how the expression
of each gene in a single cell is changing through annotating the ra-
tio of unspliced and spliced transcripts of each gene in each cell,
predicting the future state of each cell (La Manno et al., 2018).
Single-cell experiments can be performed at multiple time
points relevant to biological processes, such as lung develop-
ment, regeneration, or disease progression, generating single-
cell time-course data. Trajectory inference methods, including
STITCH (Wagner et al., 2018) and Waddington-OT (Schiebinger
et al., 2019), utilize the time of collection to supervise the analysis
and improve the accuracy of pseudotime analysis using time-
course scRNA-seq data (Wagner et al., 2018). Since data
collected at multiple time points can be influenced by technical
variations in cell isolation, library generation, and sequencing,
STITCH (Wagner et al., 2018) analyzed time-course scRNA-
seq data by first constructing a single-cell graph from each
time point and then joining pairs of graphs from adjacent time
points by connecting similar cells (Wagner et al., 2018). Wad-
dington-OT, on the other hand, directly estimates a transitional
probability between any two cells from consecutive time points
in a time-course scRNA-seq data without explicitly inferring a
lineage topology (Schiebinger et al., 2019). Given a set of cells
at a time point, Waddington-OT predicts the most likely ancestor
cells in earlier time points and descent cells in later time points
based on the derived cell-cell transition probabilities, recon-
structing a cell transitional path across time points. Importantly,
these cellular trajectory models require experimental validation
either in the form of cell-type-specific genetic lineage tracing in
mice or the use of cellular barcoding strategies in non-murine
systems such as was performed in a recent study to predict
the differentiation of lung epithelial progenitors from pluripotent
stem cells (Hurley et al., 2020).
Single-cell analysis has been used extensively to assess both
mouse and human lung development and disease. Improved
scRNA-seq methods carefully coupled with cell-type-specific
lineage tracing has uncovered new developmental and regener-
ative origins for multiple lung cell lineages. The early specifica-
tion of AT1 and AT2 cells, coincident with such early and basic
tissue patterning processes such as branching morphogenesis,
and the heterogeneity of embryonic alveolar epithelial progeni-
tors, was recently uncovered using scRNA-seq methods (Frank
et al., 2019; Guo et al., 2019). The heterogeneity within the adult
lung mesenchyme was recently described and revealed the
importance of the mesenchymal niche in alveolar homeostasis
and regeneration (Guo et al., 2019; Lee et al., 2017; Zepp
et al., 2017). Human lung scRNA-seq has been reported in
both ‘‘normal’’ lungs and in diseased lungs such as idiopathic
pulmonary fibrosis (Reyfman et al., 2019; Xu et al., 2016).
scRNA-seq was also used to identify the ionocyte, which is
thought to play a key role in cystic fibrosis (Montoro et al.,
2018; Plasschaert et al., 2018).
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man lung cell atlas including the NIH-supported LungMAP and
the Chan-Zuckerberg-supported Human Cell Atlas. One of the
major hurdles in using single-cell techniques to map the human
lung is the high level of cell heterogeneity that exists in the organ,
which means that isolation procedures including both upstream
and downstream processing are going to be highly variable de-
pending on the site and research group involved. These issues
are revealed in many experiments that lack significant represen-
tation of fragile cells such as AT1 cells and over-representation of
immune cells. In the absence of procedures and protocols that
generate highly reproducible isolation of all known cell types,
both qualitatively and quantitatively, across most if not all lung
samples, the resulting datasets are unlikely to provide an accu-
rate cell atlas. Moreover, the respiratory system is highly com-
plex and contains many spatially restricted compartments and
niches which need to be uniquely sampled, possibly using
different techniques for each region. Thus, much work remains
to be done to ensure that such single-cell mapping efforts can
reproducibly isolate and characterize all resident and immune
cells within the human respiratory system.
Bioengineering of the Whole Lung
Bioengineering of the lung has made remarkable progress in the
recent years, motivated by strong clinical needs and enabled by
advances in tissue engineering and stem cell biology. As many
as 25 million people suffer from end-stage lung disease in the
United States alone, with 400,000 patients dying each year, a
third of these from nonmalignant diseases (OPTN, 2012; Morri-
sey and Hogan, 2010; Petersen et al., 2010). Worldwide, lung
disease remains the third leading cause of death (Murphy
et al., 2018; Rabe et al., 2007). Notably, most lung diseases
affect epithelium, including the acute respiratory distress syn-
drome (ARDS), chronic obstructive pulmonary disease (COPD),
emphysema, cystic fibrosis (CF), and pulmonary fibrosis.
Lung transplantation, the only definitive treatment option for
end-stage lung disease, remains hampered by a severe shortage
of donor organs. In addition, a majority of donor lungs are
deemed unacceptable for transplantation at the time of receipt
(Ware et al., 2002), making lung the least utilized solid organ
and necessitating the use of extracorporeal membrane oxygen-
ation (ECMO) as a bridge to transplant for critically ill patients
(Fuehner et al., 2012; Javidfar and Bacchetta, 2012; Klein
et al., 2010; Pomfret et al., 2008; Ware et al., 2002).
To overcome this crisis, there are major efforts to increase the
number of transplantable lungs, including (1) criteria expansion,
i.e., accepting older donors, lungs donated following cardiac
death (Bittle et al., 2013; Elgharably et al., 2015; Van Raemdonck
et al., 2009), (2) ex vivo lung perfusion (EVLP) to recover margin-
ally unacceptable donor lungs (Cypel and Keshavjee, 2015), (3)
bioengineering of functional lungs by populating decellularized
lungs or scaffolds with epithelial and vascular cells (Ott et al.,
2010; Petersen et al., 2010; Rosen et al., 2015; Wagner et al.,
2013; Wobma and Vunjak-Novakovic, 2016), and (4) utilization
of xenogeneic lungs from swine or non-human primates (Cooper
et al., 2012; Laird et al., 2016). Thus far, the number of lung trans-
plantations remains steady, resulting in the increasing waitlist
mortality (Valapour et al., 2015). New strategies are being devel-
oped to increase the numbers of lungs for transplantation by
recovering marginal quality donor lungs and developing physio-logical ex vivo platforms for modeling lung disease. The enor-
mous complexity of the lung, with its hierarchical architecture,
more than 40 cell types, and a very large area (70 m2) for gas
exchange, presents major challenges to lung recovery (Crapo
et al., 1982; Massaro and Massaro, 1996; Weibel, 1973). Finally,
generation of humanized whole lungs through stem cell comple-
mentation in other species could lead to a new source of trans-
plantable lungs (Mori et al., 2019).
Ex vivo Lung Perfusion (EVLP) and Cross-circulation with a
Living Host. Among current approaches, EVLP holds the stron-
gest potential for immediate clinical impact by recovering
marginally unacceptable donor lungs, which has been already
implemented and is being further evaluated in clinical trials (Po-
pov et al., 2015). Notably, many of the conditions that render
donor lungs unacceptable for transplantation (e.g., aspiration,
infection, pulmonary contusions) could be reversible. However,
conventional methods of donor lung preservation that involve
cold static ischemia preclude endogenous repair and recovery
(Guibert et al., 2011; Pinezich and Vunjak-Novakovic, 2019).
The field of ex vivo lung perfusion (EVLP) is now addressing
this limitation by providing initially unacceptable donor lungs
with physiologic conditions of normothermia, perfusion, and
ventilation, to recover function outside the body to a level
acceptable for transplantation (Makdisi et al., 2017; Tane
et al., 2017). Since the introduction of EVLP by Steen and col-
leagues in 2001 (Steen et al., 2001), EVLP platforms have suc-
cessfully demonstrated short-term support and recovery of
marginal quality donor lungs in pre-clinical and clinical settings
(Cypel et al., 2011; Warnecke et al., 2018). A major limitation of
EVLP is the lack of whole-body homeostasis that requires
renal, hepatic, pancreatic, and neurohormonal functions. The
current durations of clinical usage of EVLP systems are too
short for advanced therapeutic interventions (e.g., immunomo-
dulation, cell therapy) (Warnecke et al., 2012). Moreover, cur-
rent EVLP systems cannot recover the majority of unusable
donor lungs, due to the lack of appropriate physiologic milieu
for endogenous repair.
Using a clinically relevant swine model, a cross-circulation
platform has been established with the recipient support
enabling 36 h of normothermic perfusion for the maintenance
and recovery of injured lungs (O’Neill et al., 2017). In recent
studies, the duration of lung support on cross-circulation has
been extended to 4 days (Hozain et al., 2019). Cross-circulation
is actually an old technique that has been used in the past to sup-
port patients suffering from a critical but potentially reversible
illness given sufficient time for recovery (e.g., hepatic insuffi-
ciency, uremia, eclampsia) (Burnell et al., 1965, 1967; Eschbach
et al., 1964) by a healthy individual.
For extracorporeal lungs, cross-circulation was used to
extend the duration of lung maintenance ex vivo from hours to
days, by providing metabolic clearance and systemic factors
to the perfused and ventilated lung (Figure 4; O’Neill et al.,
2017). This method allowed time for multiscale therapeutic inter-
ventions, with the aid of real-time theranostic (therapeutic +
diagnostic) imaging (Kim et al., 2015b, 2017). By the end of
cross-circulation support, the lungs that were severely damaged
by ischemia or gastric aspiration exceeded transplantation
criteria, and the recipients tolerated the procedurewithout signif-
icant changes in physiologic parameters. These findings suggestCell Stem Cell 26, April 2, 2020 493
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Figure 4. Bioengineering Approach to the Recovery of Injured Lungs
Three methodological advances have been combined to enable functional recovery of lungs damaged by cold ischemia and gastric aspiration.
(A) Multiday normothermic support of extracorporeal lungs using cross-circulation with a recipient in a clinically relevant swine model.
(B) Targeted treatment of the most injured lung regions, with the preservation of the surrounding lung tissue, through the local removal of damaged cells and their
replacement with healthy therapeutic cells.
(C) Removal of injured lung epithelium from the targeted regions of the lung, with preservation of the basement membranes and the vascular compartment.
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for gene and cell therapies of the extracorporeal lungs.
Lung Bioengineering by Complete Decellularization and
Recellularization of the Lung Parenchyma and Vasculature. The
Niklason and Ott laboratories have pioneered a methodology
that involves removal of all cells from the lung and subsequent
infusion of epithelial cells into parenchymal region and endothelial
cells into the vascular region of the lung (Ott et al., 2010; Petersen
et al., 2010). However, these bioengineered lungs fail shortly upon
transplant, due to incomplete regeneration and leaky vasculature
causing alveolar edema and thrombosis (Ott et al., 2010; Petersen
et al., 2010, 2011, 2012). While this highly innovative approach
has advanced throughmanymeritorious studies, three limitations
remain: (1) the inability to restore gas exchange, (2) the inability
to maintain vascular function upon transplantation, and (3) the
need for very high cell numbers (billions) to repopulate the lung
(Petersen et al., 2010; Song et al., 2011).494 Cell Stem Cell 26, April 2, 2020Targeted Treatment of Lung Epithelium with the Preservation
of Lung Vasculature. In principle, the limitations of full decellula-
rization/recellularization of the lung could be overcome if acutely
injured donor lungs are treated to replace only the epithelium in
themost injured regions of the lung, while preserving the integrity
of the lung vasculature. Because acute injury tends to affect
some regions of the lung and not the entire lung (Raghavendran
et al., 2011), a targeted treatment could help preserve much of
the existing lung function and facilitate regeneration of the
injured regions. An alternate approach to lung bioengineering
has been developed that is based on removing damaged epithe-
lial cells from distal lungs (Dorrello et al., 2017) while maintaining
the integrity of the basement membrane, surrounding lung cells
and matrix, and the functionality of lung vasculature. Denuded
regions in the lung airway are repopulated with epithelial progen-
itors. Themaintenance of an intact vascular network was consid-
ered critical for maintaining the blood-gas barrier as well as for
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Figure 5. Macroscopic Appearance of Injured
Lungs over 36 h on Cross-circulation
(A) Gross appearance of ischemic lungs and the
corresponding thermal images for ischemic lungs
damaged by gastric aspiration. The increase in heat
exchange indicates improved vascular perfusion.
(B) Pressure-volume loops during ischemic recovery.
The increase volume and decreased pressure in-
dicates improved pulmonary function to the level
necessary for lung transplant (reproduced with
permission from O’Neill et al., 2017).
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approach was first demonstrated in the rat model, resulting in
vascularized lung grafts that supported the attachment and
growth of human adult pulmonary cells and stem-cell-derived
alveolar progenitor cells (Dorrello et al., 2017).
Targeted decellularization/recellularization of the lung epithe-
lium was achieved by introducing soluble reagents (such as
the solutions for cell removal, suspensions of therapeutic cells)
in micro-volume liquid plugs to the targeted branches of the pul-
monary airway: upper airways, small airways (bronchioles), or
the most distal lung (alveoli). Liquid plugs (only <1 mL in volume)
were instilled into the upper airway and pushed into a specific
more distal airway to form liquid film covering lung epithelium,
using programmed ventilation of the lung in conjunction with ra-
diation-free transpleural imaging (Kim et al., 2015a).
Combination of Long-Term Lung Support Ex Vivowith the Tar-
geted Treatment of Lung Epithelium. Cell replacement therapy
offers compelling prospects for the treatment of injured lungs,
if the extracellular matrix (including the basement membranes)
could be preserved. A new methodology for lung regeneration
is now under development through an integrated use of three
components: (1) extended duration of lung support ex vivo(several days) by cross-circulation with a
living host, (2) targeted treatment of the
injured regions of the lung (from conducting
airways to distal regions), with the preserva-
tion of the surrounding lung parenchyma,
and (3) selective removal and replacement
of lung epithelium with the preservation of
lung vasculature (for immediate blood sup-
ply for lung survival and function) (Figure 4).
The same issues regarding whether newly
delivered or replaced cells merit use of the
controversial term, ‘‘engraftment,’’ (indi-
cating true, durable integration of functional
cells) apply to this novel approach as dis-
cussed above (see Cell-Based Therapy for
the Respiratory System) and have not yet
been addressed.
The utility of this approach was demon-
strated in clinical-scale swine models for
recovering lungs unsuitable for transplant
due to acute injury by ischemia (O’Neill
et al., 2017) and gastric aspiration (Guen-
thart et al., 2019) (Figure 5). In both cases,
the lung epithelium was removed from
injured regions while preserving the sur-rounding cells, matrix, and intact lung vasculature (Dorrello
et al., 2017), and the denuded epithelial regions were repopu-
lated with pulmonary progenitor cells. In one study, the injured
lungs were maintained on cross-circulation support without
decline in lung function and were subjected to therapeutic inter-
ventions that enabled cellular regeneration and improved func-
tion over the course of 36 h (Guenthart et al., 2019). Regeneration
of severely damaged lungs to the levels necessary for meeting
the transplantation criteria would help significantly increase the
pool of donor lungs available for transplant, for example by
recovering lungs rejected because of gastric aspiration damage.
On cross-circulation, the injured lungs recovered their mechan-
ical compliance to 68% of that of uninjured control lungs, corre-
sponding to a 6-fold improvement relatively to the levels
measured post-injury. A lung injury scoring rubric that has been
developed in these studies (Guenthart et al., 2019; O’Neill et al.,
2017) was also used to assess the extent of lung injury over
4 days of lung maintenance and recovery (Hozain et al., 2019).
The lung injury scores decreased across all categories, with the
greatest improvements observed in alveolar cells functionality,
lung edema, and cell apoptosis. The recovered lungs displayed
regeneration of cell surface markers in the pulmonary epithelium,Cell Stem Cell 26, April 2, 2020 495
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Reviewendothelium, tight and gap junctions, recovery of subcellular
structures (e.g., intracellular vesicles), and cellular function and
integrity (Guenthart et al., 2019). Throughout the duration of extra-
corporeal support, the recipient tolerated cross-circulation with
no significant changes in physiologic parameters. After 36 h of
the procedure, the lungs injured by ischemia or gastric aspiration
exceeded transplantation criteria, as evidenced by the gross
appearance, thermography, and P-V loops that were consistent
with recovered lungs (Figure 5). Future studies may lead to inter-
ventional cross-circulation being used for the expansion of donor
lung pools through the salvage of severely damaged lungs.
Future Directions
The field of lung regeneration has advanced immensely in the
last decade. The emergence of cell-type-specific lineage tracing
coupled with better injury models has allowed investigators to
begin to directly link the behavior among the various cell lineages
in the lung and their responses to acute injury. New methods for
generating human lung cells using PSC technologies, coupled
with better imaging modalities and evolving assays such as hu-
man lung organoids and precision cut lung slices, are allowing
for the direct use of human lung tissue to experimentally and
mechanistically assess the response to acute injuries and
chronic diseases. The recent advent of single-cell genomics
and advanced bioengineering techniques allow not only for the
exquisite definition of all cell types within the human and mouse
lung but provides clinically relevant approaches to regenerate
unusable human lungs for transplant. Finally, the ongoing
COVID-19 pandemic highlights the need for a better understand-
ing of lung regeneration in the face of overwhelming acute viral
injury. Given that lung disease remains the third leading cause
of morbidity and mortality in the world, all of these advances
and many more will be needed to develop better therapeutic ap-
proaches for the many patients in need.ACKNOWLEDGMENTS
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